Kim CJ - Search Results

1

Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity.

Kim CJ, Tambe Y, Mukaisho KI, Sugihara H, Kawauchi A, Inoue H. Kim CJ, et al. Oncol Lett. 2016 Dec;12(6):4850-4856. doi: 10.3892/ol.2016.5286. Epub 2016 Oct 18. Oncol Lett. 2016. PMID: 28105192 Free PMC article.

2

[A study on the hemodialysis period following cadaveric kidney transplantation--a comparison between two centers sharing cadaver donor kidney pairs].

Pak K, Kim CJ, Inoue H, Wakabayashi Y, Watanabe J, Arai Y, Konishi T, Tomoyoshi T, Sako H, Okino K, et al. Pak K, et al. Among authors: kim cj. Nihon Hinyokika Gakkai Zasshi. 1990 Oct;81(10):1500-5. doi: 10.5980/jpnjurol1989.81.1500. Nihon Hinyokika Gakkai Zasshi. 1990. PMID: 2273700 Free article. Japanese.

3

Clinical study of aseptic necrosis of bone after renal transplantation.

Abe H, Sako H, Okino K, Nakane Y, Kodama M, Park KI, Inoue H, Kim CJ, Tomoyoshi T. Abe H, et al. Among authors: kim cj. Transplant Proc. 1994 Aug;26(4):1987. Transplant Proc. 1994. PMID: 8066643 No abstract available.

4

Nephron sparing surgery for de novo renal cell carcinoma in an allograft kidney: a case report.

Park KI, Inoue H, Kim CJ, Tomoyoshi T. Park KI, et al. Among authors: kim cj. Int J Urol. 1997 Nov;4(6):611-4. doi: 10.1111/j.1442-2042.1997.tb00319.x. Int J Urol. 1997. PMID: 9477194 Free article.

5

Azathioprine-induced megaloblastic anemia with pancytopenia 22 years after living-related renal transplantation.

Kim CJ, Park KI, Inoue H, Yoshida T, Yoshiki T, Tomoyoshi T, Abe H, Kodama M, Sako H, Nakane Y. Kim CJ, et al. Int J Urol. 1998 Jan;5(1):100-2. doi: 10.1111/j.1442-2042.1998.tb00250.x. Int J Urol. 1998. PMID: 9535611 Free article.

6

Down-regulation of drs mRNA in human prostate carcinomas.

Kim CJ, Shimakage M, Kushima R, Mukaisho K, Shinka T, Okada Y, Inoue H. Kim CJ, et al. Hum Pathol. 2003 Jul;34(7):654-7. doi: 10.1016/s0046-8177(03)00240-5. Hum Pathol. 2003. PMID: 12874760

7

Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells.

Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okamoto K. Kawakami T, et al. Among authors: kim cj. Oncogene. 2004 Aug 12;23(36):6163-9. doi: 10.1038/sj.onc.1207808. Oncogene. 2004. PMID: 15195139

8

Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.

Kim CJ, Yoshioka N, Tambe Y, Kushima R, Okada Y, Inoue H. Kim CJ, et al. Int J Cancer. 2005 Oct 20;117(1):51-8. doi: 10.1002/ijc.21120. Int J Cancer. 2005. PMID: 15880581

9

Role of alternative splicing of periostin in human bladder carcinogenesis.

Kim CJ, Isono T, Tambe Y, Chano T, Okabe H, Okada Y, Inoue H. Kim CJ, et al. Int J Oncol. 2008 Jan;32(1):161-9. Int J Oncol. 2008. PMID: 18097555

10

Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.

Kim CJ, Nishi K, Isono T, Okuyama Y, Tambe Y, Okada Y, Inoue H. Kim CJ, et al. Mol Carcinog. 2009 Oct;48(10):953-64. doi: 10.1002/mc.20547. Mol Carcinog. 2009. PMID: 19415719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,496 results

Search Page

Filters